Zhanping Wu
@Vivo Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$1.208BTotal holdings43
Assets growth rate11.63%Assets growth rate (2-Q avg)-1.65%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Vivo Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 43 positions.
Assets under management
The assets under management (AUM) of Vivo Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.208B in assets, with a quarterly growth rate of 11.63% and a 2-quarter average growth rate of -1.65%. The portfolio is managed by Zhanping Wu, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SLNOSoleno Therapeutics Inc
| 26.3% | $317.676M 6.292M shares@ $50.5 avg price | Decreased -14% |
GERNGeron Corp
| 10.23% | $123.603M 27.225M shares@ $4.55 avg price | |
HRMYHarmony Biosciences Holdings Inc
| 8.63% | $104.25M 2.606M shares@ $40.0 avg price | |
VRNAVerona Pharma Plc
| 8.46% | $102.127M 3.55M shares@ $28.78 avg price | |
SVASinovac Biotech Ltd.
| 6.32% | $76.346M 11.8M shares@ $6.47 avg price | |
TERNTerns Pharmaceuticals Inc
| 4.76% | $57.511M 6.896M shares@ $8.35 avg price | Increased 11.53% |
TILInstil Bio Inc
| 3.48% | $42.031M 624,339 shares@ $67.32 avg price | |
DYNDyne Therapeutics Inc
| 3.32% | $40.049M 1.115M shares@ $35.92 avg price | Decreased -31.81% |
VRDNViridian Therapeutics Inc
| 3.16% | $38.179M 1.678M shares@ $22.75 avg price | |
AVDLAvadel Pharmaceuticals Plc
| 2.92% | $35.202M 2.684M shares@ $13.12 avg price | New Position |